Edwards Lifesciences Corp

NYSE: EW
$88.61
+$0.86 (+1.0%)
Closing price April 24, 2024
Edwards Lifesciences Corp specializes in innovative solutions for heart disease and critical care monitoring worldwide. It's known for its Edwards SAPIEN family of valves, offering minimally invasive aortic valve replacements. The company also tackles mitral and tricuspid valve diseases with its PASCAL PRECISION and Cardioband systems. Beyond valve solutions, Edwards provides surgical and critical care products like the INSPIRIS RESILLA aortic valve and advanced hemodynamic monitoring systems. Founded in 1958 and based in Irvine, California, Edwards Lifesciences is a pioneer in improving patient outcomes in heart care and intensive care units.
Credit Suisse has assembled its favorite health care recovery stocks for a recovering base of elective surgeries and for the risk of rising hospitalizations that go well beyond COVID-19.
Friday's top analyst upgrades and downgrades included American Airlines, Chipotle Mexican Grill, Ericsson, Microsoft, Mylan, Novavax, Pfizer, Procter & Gamble, Qualcomm, Square and Starbucks.
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, Alexion Pharmaceuticals, Avis Budget, DexCom, Johnson & Johnson, Marvell Technology, Moderna, Snap, Splunk...
Thursday's top analyst upgrades, downgrades and initiations included Applied Materials, Cisco Systems, Cognizant Technology Solutions, Costco Wholesale, Enphase Energy, Medtronic, Shopify, Starbucks,...
Top analyst upgrades, downgrades and initiations for the first trading day of 2020 included Abbott Laboratories, Advanced Micro Devices, Analog Devices, Applied Materials, Ford, Illumina, Medtronic,...
Wednesday's top analyst upgrades, downgrades and initiations include Amarin, Baker Hughes, Canopy Growth, Home Depot, Intelsat, Johnson & Johnson, Replimune, Schlumberger and Transocean.
Jefferies highlights its top growth stocks to buy each week, and this week is no exception. These four stocks make good sense now, and they have outstanding upside potential.
Monday's top analyst upgrades, downgrades and initiations included Alcoa, Amgen, Apache, Chewy, Clorox, Concho Resources, Edwards Lifesciences, Occidental Petroleum and Walt Disney.
While these four stocks are better suited for accounts that have a higher risk tolerance, they all make good sense now, and all have outstanding upside potential.
Monday was a positive day for the broad U.S. markets. All three of the major exchanges posted solid gains in the session. The DJIA is closing in on 26,000 yet again, and one more positive session...
The top analyst upgrades, downgrades and initiations seen on Friday included Bank of America, Caterpillar, Chevron, CSX, Kimberly-Clark, Nautilus, Netflix, Signet Jewelers and Valero Energy.
Tuesday was a positive day for the broad U.S. markets. Initially the futures for the S&P 500 and DJIA were negative on Tuesday morning, but this quickly turned around as soon as markets opened...
A Credit Suisse analyst issued a broad new sector coverage for medical devices and related companies with strong Outperform ratings on Tuesday.
The top analyst upgrades, downgrades and initiations seen on Tuesday included Abbott Laboratories, Albermarle, Boston Scientific, BP, Embraer, Intuit, Marathon Oil and Norfolk Southern.
The top analyst upgrades, downgrades and initiations seen on Friday included Apple, Broadcom, Chesapeake Energy, Devon Energy, Lululemon Athletica, SecureWorks, Tesla and Zendesk.